FMC expects $625M-$675M in charges from price cuts and a U.S. pricing shift.
FMC Corporation (NYSE:FMC) revised its Q3 2026 expectations, anticipating revenue of $510M and adjusted EBITDA between -$125M and -$565M due to price cuts and U.S. pricing shifts, totaling $625M-$675M in charges. The company cited weaker demand and high inventory levels as reasons for the adjustments. FMC plans to modify its pricing model and accelerate product movement to support future demand. The company will provide more details during its Q3 earnings call on October 29, 2026.
How this was made
The 30-second read
Why it matters
The guidance reduction suggests a short‑term earnings miss, prompting sell pressure.
Market read
FMC's guidance cut is a material new fact that can move the stock ahead of its earnings call.
What to watch
Potential upside from upcoming product launches and cost‑reduction initiatives not detailed in the release.
Background
FMC updated its Q3 2026 outlook, citing commercial actions to address high‑priced inventory and generic competition.
Ticker impact
FMC announced $625M‑$675M of commercial‑action charges that will reduce Q3 revenue and Adjusted EBITDA.
likely downside pressure as investors price in lower revenue and EBITDA.
The disclosed charge range is material for a mid‑cap agriscience company and comes before the upcoming earnings release.
Market effects
May weigh on broader agricultural chemicals sector as peers face pricing pressure.
U.S. agriscience stocks could see modest pullback.
Limited to sector; no broad market impact expected.
Counterpoint
If the commercial actions successfully clear excess inventory, future quarters could see a rebound.
Key entities
- ExecutivePierre Brondeau
Chairman, CEO and President of FMC, quoted on the commercial actions.

